SpringWorks
@springworkstx
At SpringWorks, we bring tenacity to work every day because patients need answers now.
ID: 867536041376452609
http://www.springworkstx.com 25-05-2017 00:21:25
746 Tweet
619 Takipçi
152 Takip Edilen
The FDA has granted Priority Review to our New Drug Application for our investigational MEK inhibitor for children and adults with #NF1-PN. Our EU Marketing Authorization submission has also been validated by the European Medicines Agency. Learn more: ir.springworkstx.com/news-releases/…
